MedPath

Monitoring Resuscitation in Severe Sepsis and Septic Shock

Not Applicable
Conditions
Hemodynamics
Interventions
Behavioral: Dynamic-parameters-guided fluid management
Behavioral: Standard-guided-fluid management
Registration Number
NCT01747057
Lead Sponsor
Corporacion Parc Tauli
Brief Summary

Our hypothesis is that hemodynamic fluid resuscitation guided by dynamic parameters will improve outcome in patients with severe sepsis and septic shock, by limiting the deleterious effects of fluid overload.

Detailed Description

To evaluate the efficacy of dynamic parameters versus static measures to guide fluid resuscitation we pretend to detect a 10% relative reduction in mortality. In addition, we pretend to observe an improvement on the length of resuscitation time, mechanical ventilation and vasopressor support-free days, ICU and hospital length of stay, organ failure and renal function.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
952
Inclusion Criteria
  • Age > 18 years

  • Clinical evidence of sepsis (microbiology confirmation, radiological or direct view - pus in biological fluid or surgical direct view-).

  • ≥ 2 SIRS criteria:

    • Temperature < 36.0°C or > 38.0°C
    • Heart rate > 90 bpm
    • Respiratory rate > 20 rpm or PaCO2 < 32 mmHg or need of mechanical ventilation.
    • Leukocytes > 12.0 x109/L or < 4.0 x109/L
  • Hemodynamic insufficiency defined as (at least one of the following):

    • Sustained systemic hypotension (systolic arterial pressure ≤ 90 mmHg or MAP < 65 mmHg) or a decrease in MAP of > 30 mm Hg in a hypertensive patient.
    • Need of vasopressors.
    • Tachycardia (HR > 110 bpm) or bradycardia (HR < 55 bpm)
    • Acute onset of oliguria, defined as a decreased urine output < 0.5 ml/kg/hr for ≥ 2 hours
    • Serum lactate > 2 mmol/l
    • Peripheral cyanosis, mottled skin, prolonged capillary refill
  • Mechanical ventilation without any kind of inspiratory effort and Vt 7-10 mL/Kg, Pplateau < 30 mmH2O. Those patients with ARDS under mechanical ventilation will need to tolerate a tidal volume of at least 7 mL/Kg during 30 seconds while the plateau pressure remains < 30 mmH2O.

  • Prior hemodynamic monitoring by arterial catheter.

  • Central venous catheter.

Exclusion Criteria
  • Acute myocardial infarction < 7 days.
  • Pregnancy
  • Prior request of limited code status or expected life length lower than 3 months.
  • Shock > 12h
  • Cardiac arrhythmia
  • Aortic valvular disease
  • Inability to properly measure arterial pressure wave forms

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dynamic guide resuscitationDynamic-parameters-guided fluid managementThis arm follows a resuscitation protocol based on dynamic-parameters-guided fluid management.
Standard resuscitationStandard-guided-fluid managementThis arm follows a common resuscitation protocol based on Surviving Sepsis Campaign recommendations.
Primary Outcome Measures
NameTimeMethod
Mortality at 28 days28 days after hospital admission
Secondary Outcome Measures
NameTimeMethod
Length of resuscitation72 hours after protocol inclusion

* Vasopressor use and fluid load between 0h to 6h

* Vasopressor use and fluid load between 7h to 72h

Ventilator-free days28 days after admission

From 1 to 28 days over 28 days in a month.

Vasopressor-free days28 days after admission

From 1 to 28 days over 28 days in a month.

Organ failure-free days28 days after admission

Cardiovascular, CNS, renal, hepatic, coagulation abnormalities. From 1 to 28 days over 28 days in a month.

ICU length of stayAt ICU discharge (expected average 30 days after admission)
Hospital length of stayAt hospital discharge (expected average 45 days after hospital admission)
Renal function evolution3 days after study enrollment

Creatinin clearance will be calculated every day for the first 3 days (Cockroft-Gault formula).

Mortality at 3 months3 months after admission

Trial Locations

Locations (1)

Area de Critics. Hospital de Sabadell

🇪🇸

Sabadell, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath